Tessera
Folgen

Carthera

@carthera.bsky.social

#MedTech #startup developing innovative therapeutic ultrasound-based medical devices to treat brain disorders 🧠 🖥️ Website: carthera.eu 🥼 Glioblastoma trial: sonobird.eu #Oncology #Neurology #Glioblastoma #Alzheimers #SonoCloud

104 Posts95 Follower149 Folgt
Carthera@carthera.bsky.social · 11mo ago

📢 Update: this account will no longer be active. Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/ We look forward to staying connected with you there!

Carthera | LinkedIn

Carthera | 6,995 followers on LinkedIn. Advanced Brain Therapy | Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range o...

linkedin.com

Carthera@carthera.bsky.social · 12mo ago

Finding a #braintumor clinical trial can be overwhelming. That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai

Ancora - Find Cancer Clinical Trials

Ancora is a search tool that enables cancer patients to find relevant clinical trials in minutes. Radiopharmaceutical trial finder, nuclear medicine.

ancora.ai

Carthera@carthera.bsky.social · 12mo ago

GLIOBLASTOMA TRIAL UPDATE 📣 Sonobird is now active in Denmark! 🇩🇰 Two weeks ago, the team at University of Copenhagen included the first Danish patient. To learn more about the trial including active recruitment centres 👇 sonobird.eu #Glioblastoma #ClinicalTrial #NeuroOncology

SONOBIRD: a pivotal trial in recurrent glioblastoma

SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...

sonobird.eu

Carthera@carthera.bsky.social · last yr.

This trial involves 40+ clinical sites in the EU & US, evaluating our SonoCloud device to temporarily open the blood-brain barrier and enhance chemotherapy delivery for recurrent #glioblastoma patients Learn more about the trial and clinical sites in Italy👇 sonobird.eu #clinicaltrials #medtech

SONOBIRD: a pivotal trial in recurrent glioblastoma

SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...

sonobird.eu

Carthera@carthera.bsky.social · last yr.

📣 We’re thrilled to announce that our phase 3 trial for recurrent #glioblastoma has launched in Italy with the first patient enrolled in Bologna 🇮🇹 Prof. Giuseppe Lombardi, Italy’s referring investigator and site lead in Padua recently spoke about the trial. Watch the interview👇 bit.ly/4msq3gX

Padova, un "device" a ultrasuoni per combattere il glioblastoma

Affidato allo Iov il coordinamento di un innovativo progetto internazionale per rendere molto più efficaci le terapie per contrastare questo aggressivo tumore cerebrale

bit.ly

Carthera@carthera.bsky.social · last yr.

A new study has identified genes responsible for the spread of #glioblastoma, opening up new avenues for treatment. This breakthrough could pave the way for more effective therapies and improved patient outcomes. Learn more👇 www.insideprecisionmedicine.com/topics/oncol... #BrainTumor #Oncology

Genes Causing Spread of Glioblastoma Open Treatment Avenues

New research shows how glioblastoma cells infiltrate the brain and which key genes drive the invasion, paving the way to new treatments.

insideprecisionmedicine.com

Carthera@carthera.bsky.social · last yr.

🧠 On #GlioblastomaDay, we stand with the global call for better awareness, research & treatments. Only four FDA-approved drugs & one device exist, we are working to change this through our SonoCloud system. Read Lynn's story - a patient in our Sonobird trial👇 www.med.unc.edu/neurosurgery...

Glioblastoma Patient Joins the Sonobird Clinical Trial at UNC Health | Department of Neurosurgery

Lynn lives an active lifestyle as an owner of her own luxury traveling tours business. But when she got back from a corporate cruise in November of 2023, she started to feel sick every day. Lynn was q...

med.unc.edu

Carthera@carthera.bsky.social · last yr.

Our CSO was recently featured on the PsyDactic podcast! 📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera? Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis... #Ultrasound #Research #Podcast

Therapeutic Ultrasound with Dr. Michael Canney PhD - PsyDactic

This episode includes a fascinating interview with a researcher in ultrasound, Dr. Michael Canney who is an acoustics researcher the chief scientific officer at a French company named Carthera (https:...

psydactic.buzzsprout.com

Carthera@carthera.bsky.social · last yr.

Le Pr. Olivier Chinot de @aphm-chu-marseille.bsky.social était ce matin sur @bfmmarseille.bsky.social 📽️ Découvrez comment notre technologie innovante est en train de changer la donne dans la lutte contre le cancer du cerveau www.bfmtv.com/marseille/re... #glioblastome #Santé #RechercheMédicale

Marseille: une solution pour traiter le cancer du cerveau

VIDÉO - Le professeur Olivier Chinot, neuro-oncologue à l'APHM, présente un essai clinique innovant pour traiter le glioblastome, un cancer du cerveau.

bfmtv.com

Carthera@carthera.bsky.social · last yr.

How do we overcome the blood-brain barrier ? 🧠 Despite advancements in #glioblastoma treatment, the BBB remains a critical obstacle. In this Cureus article, part of Springer Nature, the authors suggest that one of the most promising uses of FUS is BBB disruption. www.cureus.com/articles/353...

Overcoming the Blood-Brain Barrier: Focused Ultrasound in Glioblastoma Treatment

Despite recent advancements in neuro-oncology, glioblastoma remains one of the cancers with the poorest prognosis. Tumor recurrence and progression are driven by tumor stem cells and a high mutational...

cureus.com

Carthera@carthera.bsky.social · last yr.

Don't miss this article from NewYork-Presbyterian and @columbiacancer.bsky.social spotlighting our SONOBIRD trial Huge thanks to Dr. Brian Gill and the team of researchers and clinicians driving this innovation www.nyp.org/advances/art... #Glioblastoma #BrainTumor #ClinicalTrials

Disrupting the Blood-Brain Barrier to Improve Glioblastoma Treatment | Spotlight | Advances in Neurology and Oncology | NewYork-Presbyterian

NewYork-Presbyterian neurosurgeon Dr. Brian Gill describes the SONOBIRD trial, which tests a new implantable ultrasound device that may improve drug delivery to the brain to treat glioblastoma.

nyp.org

Carthera@carthera.bsky.social · last yr.

This weekend, our Chief Scientific Officer spoke with @foxnews.com.web.brid.gy to break down what people should know about glioblastoma following Michael Bolton's diagnosis, and how Carthera is advancing progress toward new breakthroughs in treatment delivery. Full article: bit.ly/42ZTdM9

Michael Bolton had strange symptoms before brain cancer diagnosis: ‘Something’s wrong’

A Grammy-winning singer who was diagnosed in December 2023 with glioblastoma—the most aggressive and rapidly progressing type of brain cancer—began showing signs that something was wrong the previous ...

bit.ly

Carthera@carthera.bsky.social · last yr.

Our innovative SonoCloud technology has been used to treat the first glioblastoma patient in Florida! A huge thank you to @moffittnews.bsky.social for their dedication and expertise in making this possible. Want to learn more ? www.moffitt.org/endeavor/arc... #Glioblastoma #ClinicalTrials

Moffitt Treats First Glioblastoma Patient in Florida Using New Technology

Carthera’s Sonocloud-9 could eliminate challenges presented by the blood-brain barrier

moffitt.org

Carthera@carthera.bsky.social · last yr.

🥼University of Minnesota researchers are developing a cell therapy that would combat Alzheimer’s disease using strategies used in blood cancer treatment 👉https://bit.ly/42IJb2a #Alzheimers #Neurology #CellTherapy

UMN researchers developing cell therapy to combat Alzheimer’s disease

Researchers from the University of Minnesota are developing a cell therapy that would combat Alzheimer’s disease using strategies used in blood cancer treatment, according to a press release. The cell...

mndaily.com